| Iopamidol |
20050028 |
SCANLUX 370, Solution for injection, 370 mg I/ml - 200 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Impfstoffwerk Dessau-Tornau GmbH, Germany; Sanochemia Pharmazeutika AG, Austria |
1094.38 |
218.88 |
1313.26 |
4% |
10 |
1104.38 |
220.88 |
1325.26 |
16% |
25 |
1129.38 |
225.88 |
1355.26 |
|
НСР-1465/21.10.2013 |
11.11.2013 |
11.11.2013 |
Неактивен |
3483 |
| Iopamidol |
20050028 |
SCANLUX 370, Solution for injection, 370 mg I/ml - 100 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Impfstoffwerk Dessau-Tornau GmbH, Germany; Sanochemia Pharmazeutika AG, Austria |
465.1 |
93.02 |
558.12 |
4% |
10 |
475.1 |
95.02 |
570.12 |
16% |
25 |
500.1 |
100.02 |
600.12 |
|
НСР-1469/21.10.2013 |
11.11.2013 |
11.11.2013 |
Неактивен |
2999 |
| Iopamidol |
ІІ-10244/14.01.2005 г. |
SCANLUX 370, Solution for injection, 370 mg I/ml - 50 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Impfstoffwerk Dessau-Tornau GmbH, Germany; Sanochemia Pharmazeutika AG, Austria |
283.93 |
56.79 |
340.72 |
4% |
10 |
293.93 |
58.79 |
352.72 |
16% |
25 |
318.93 |
63.79 |
382.72 |
|
КЦ-1086/07.08.2009 |
25.08.2009 |
25.08.2009 |
Неактивен |
807 |
| Iopamidol |
ІІ-10244/14.01.2005 г. |
SCANLUX 370, Solution for injection, 370 mg I/ml - 200 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Impfstoffwerk Dessau-Tornau GmbH, Germany; Sanochemia Pharmazeutika AG, Austria |
1117.99 |
223.6 |
1341.59 |
4% |
10 |
1127.99 |
225.6 |
1353.59 |
16% |
25 |
1152.99 |
230.6 |
1383.59 |
|
КЦ-1086/07.08.2009 |
25.08.2009 |
25.08.2009 |
Неактивен |
3483 |
| Iopamidol |
ІІ-10244/14.01.2005 г. |
SCANLUX 370, Solution for injection, 370 mg I/ml - 100 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Impfstoffwerk Dessau-Tornau GmbH, Germany; Sanochemia Pharmazeutika AG, Austria |
559 |
111.8 |
670.8 |
4% |
10 |
569 |
113.8 |
682.8 |
16% |
25 |
594 |
118.8 |
712.8 |
|
КЦ-1086/07.08.2009 |
25.08.2009 |
25.08.2009 |
Неактивен |
2999 |
| Telbivudine |
EU/1/07/388/001 |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Europharm Limited, UK |
641.26 |
128.25 |
769.51 |
4% |
10 |
651.26 |
130.25 |
781.51 |
16% |
25 |
676.26 |
135.25 |
811.51 |
Промяна на обстоятелствата НСР-16308/27.07.2018 |
КЦРР-2220/06.02.2013 г; НСР-13881/25.09.2017; НСР-15743/25.05.2018 |
09.06.2018 |
02.09.2018 |
Активен |
1630 |
| Telbivudine |
EU/1/07/388/001 |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Europharm Limited, UK |
641.26 |
128.25 |
769.51 |
4% |
10 |
651.26 |
130.25 |
781.51 |
16% |
25 |
676.26 |
135.25 |
811.51 |
Промяна на обстоятелствата НСР-16308/27.07.2018 |
КЦРР-2220/06.02.2013 г; НСР-13881/25.09.2017; НСР-15743/25.05.2018 |
09.06.2018 |
02.09.2018 |
Неактивен |
1630 |
| Telbivudine |
0332/25.07.2007 г. |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Europharm Limited, UK |
641.26 |
128.25 |
769.51 |
4% |
10 |
651.26 |
130.25 |
781.51 |
16% |
25 |
676.26 |
135.25 |
811.51 |
|
КЦРР-2220/06.02.2013 г; НСР-13881/25.09.2017; НСР-15743/25.05.2018 |
09.06.2018 |
02.07.2018 |
Неактивен |
1630 |
| Telbivudine |
0332/25.07.2007 г. |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Europharm Limited, UK |
645.13 |
129.03 |
774.16 |
4% |
10 |
655.13 |
131.03 |
786.16 |
16% |
25 |
680.13 |
136.03 |
816.16 |
|
КЦРР-2220/06.02.2013 г; НСР-13881/25.09.2017 |
10.10.2017 |
02.11.2017 |
Неактивен |
1630 |
| Telbivudine |
0332/25.07.2007 г. |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Europharm Limited, UK |
647.22 |
129.44 |
776.66 |
4% |
10 |
657.22 |
131.44 |
788.66 |
16% |
25 |
682.22 |
136.44 |
818.66 |
|
КЦРР-2220/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
1630 |
| Telbivudine |
EU/1/07/388/001 |
SEBIVO, Film coated tablet, 600, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma S.A.S., France |
711.92 |
142.38 |
854.3 |
4% |
10 |
721.92 |
144.38 |
866.3 |
16% |
25 |
746.92 |
149.38 |
896.3 |
|
КЦ-269/05.11.2008 |
21.11.2008 |
21.11.2008 |
Неактивен |
1630 |
| Glycopyrronium bromide |
EU/1/12/788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
Промяна на обстоятелствата НСР-16614/24.08.2018 |
НСР-3975/30.06.2014; HCP-10171/31.08.2016; НСР-12739/19.05.2017; НСР-15168/02.03.2018; НСР-18672/20.05.2019 |
04.06.2019 |
02.07.2019 |
Активен |
2997 |
| Glycopyrronium bromide |
EU/1/12/788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
46.92 |
9.38 |
56.3 |
4% |
1.88 |
48.8 |
9.76 |
58.56 |
16% |
7.51 |
56.31 |
11.26 |
67.57 |
Промяна на обстоятелствата НСР-16614/24.08.2018 |
НСР-3975/30.06.2014; HCP-10171/31.08.2016; НСР-12739/19.05.2017; НСР-15168/02.03.2018 |
17.03.2018 |
02.10.2018 |
Неактивен |
2997 |
| Glycopyrronium bromide |
EU/1/12/788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
46.92 |
9.38 |
56.3 |
4% |
1.88 |
48.8 |
9.76 |
58.56 |
16% |
7.51 |
56.31 |
11.26 |
67.57 |
|
НСР-3975/30.06.2014; HCP-10171/31.08.2016; НСР-12739/19.05.2017; НСР-15168/02.03.2018 |
17.03.2018 |
02.04.2018 |
Неактивен |
2997 |
| Glycopyrronium bromide |
EU/1/12/788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
47.51 |
9.5 |
57.01 |
4% |
1.9 |
49.41 |
9.88 |
59.29 |
16% |
7.6 |
57.01 |
11.4 |
68.41 |
|
НСР-3975/30.06.2014; HCP-10171/31.08.2016; НСР-12739/19.05.2017 |
03.06.2017 |
02.07.2017 |
Неактивен |
2997 |
| Glycopyrronium bromide |
EU/1/12/ 788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
47.53 |
9.51 |
57.04 |
4% |
1.9 |
49.43 |
9.89 |
59.32 |
16% |
7.6 |
57.03 |
11.41 |
68.44 |
|
НСР-3975/30.06.2014; HCP-10171/31.08.2016 |
02.10.2016 |
02.10.2016 |
Неактивен |
2997 |
| Glycopyrronium bromide |
EU/1/12/ 788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
49.29 |
9.86 |
59.15 |
4% |
1.97 |
51.26 |
10.25 |
61.51 |
16% |
7.89 |
59.15 |
11.83 |
70.98 |
|
НСР-3975/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
2997 |
| Glycopyrronium bromide |
EU/1/12/788/003 |
Seebri Breezhaler, Inhalation powder, hard capsule, 44, mcg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg, Germany |
59.65 |
11.93 |
71.58 |
4% |
2.39 |
62.04 |
12.41 |
74.45 |
16% |
9.54 |
71.58 |
14.32 |
85.9 |
|
НСР-1459/21.10.2013 |
05.11.2013 |
05.11.2013 |
Неактивен |
2997 |
| Cefpodoxime proxetil |
20110744 |
Sefpotec, Film coated tablet, 200, mg, Pack: 14 |
Нобел Фарма ЕООД, България |
Нобел Фарма ООД, България |
17.6 |
3.52 |
21.12 |
6% |
1.06 |
18.66 |
3.73 |
22.39 |
18% |
3.17 |
21.83 |
4.37 |
26.2 |
|
НСР-6512/18.06.2015 |
04.07.2015 |
04.07.2015 |
Активен |
4022 |
| Cefpodoxime proxetil |
20110744 |
Sefpotec, Film coated tablet, 200, mg, Pack: 10 |
Нобел Фарма ЕООД, България |
НОБЕЛ ФАРМА ООД България |
13.69 |
2.74 |
16.43 |
6% |
0.82 |
14.51 |
2.9 |
17.41 |
18% |
2.46 |
16.97 |
3.39 |
20.36 |
|
КЦРР-1257/13.08.2012 |
14.09.2012 |
14.09.2012 |
Активен |
1341 |
| Lacosamide |
20180007 |
Seizpat, Film coated tablet, 50, mg, Pack: 56 |
Mylan Ireland Limited, Ирландия |
HBM Pharma s.r.o, Словакия; Mylan Hungary Kft., Унгария |
30.3 |
6.06 |
36.36 |
4% |
1.21 |
31.51 |
6.3 |
37.81 |
16% |
4.85 |
36.36 |
7.27 |
43.63 |
Промяна на обстоятелства НСР-18005/21.02.2019 |
НСР-16460/17.08.2018 |
02.10.2018 |
02.04.2019 |
Активен |
16274 |
| Lacosamide |
20180007 |
Seizpat, Film coated tablet, 50, mg, Pack: 56 |
Mylan Ireland Limited, Ирландия |
HBM Pharma s.r.o, Словакия; Mylan Hungary Kft., Унгария |
30.3 |
6.06 |
36.36 |
4% |
1.21 |
31.51 |
6.3 |
37.81 |
16% |
4.85 |
36.36 |
7.27 |
43.63 |
Промяна на обстоятелства НСР-18005/21.02.2019 |
НСР-16460/17.08.2018 |
02.10.2018 |
02.04.2019 |
Неактивен |
16274 |
| Lacosamide |
20180008 |
Seizpat, Film coated tablet, 100, mg, Pack: 56 |
Mylan Ireland Limited, Ирландия |
HBM Pharma s.r.o, Словакия; Mylan Hungary Kft., Унгария |
59.95 |
11.99 |
71.94 |
4% |
2.4 |
62.35 |
12.47 |
74.82 |
16% |
9.59 |
71.94 |
14.39 |
86.33 |
Промяна на обстоятелства НСР-18003/21.02.2019 |
НСР-16460/17.08.2018 |
02.10.2018 |
02.04.2019 |
Активен |
16275 |
| Lacosamide |
20180008 |
Seizpat, Film coated tablet, 100, mg, Pack: 56 |
Mylan Ireland Limited, Ирландия |
HBM Pharma s.r.o, Словакия; Mylan Hungary Kft., Унгария |
59.95 |
11.99 |
71.94 |
4% |
2.4 |
62.35 |
12.47 |
74.82 |
16% |
9.59 |
71.94 |
14.39 |
86.33 |
Промяна на обстоятелства НСР-18003/21.02.2019 |
НСР-16460/17.08.2018 |
02.10.2018 |
02.04.2019 |
Неактивен |
16275 |
| Lacosamide |
20180009 |
Seizpat, Film coated tablet, 200, mg, Pack: 56 |
Mylan Ireland Limited, Ирландия |
HBM Pharma s.r.o, Словакия; Mylan Hungary Kft., Унгария |
119.83 |
23.97 |
143.8 |
4% |
4.79 |
124.62 |
24.92 |
149.54 |
16% |
19.17 |
143.79 |
28.76 |
172.55 |
Промяна на обстоятелства НСР-18001/21.02.2019 |
НСР-16460/17.08.2018 |
02.10.2018 |
02.04.2019 |
Активен |
16276 |